Healthcare -
Biotechnology - NASDAQ - NL
$ 20.93
-0.333 %
$ 2.3 B
Market Cap
-8.18
P/E
NAMS - STOCK-BASED COMPENSATION
Stock-based Compensation NAMS - NewAmsterdam Pharma Company N.V.
24.6 M
LAST VALUE
344.44%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR